ACE2 and infection: Most vaccines developed against SARS-CoV-2 induce an immune response toward the receptor-binding domain (RBD), a portion of the spike protein present at the S1 region, which is essential for binding the virus to angiotensin-converting enzyme-2 (ACE2) on the cell surface and to establish cellular infection [8].